The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

AmpliPhi Biosciences - Focused on Developing Therapies for Antibiotic-Resistant Infections Using Bacteriophage-based Technology

SNNLive spoke with Steve Martin, CFO of AmpliPhi Biosciences Corporation (NYSE MKT: APHB), at the LD Micro Invitational 2017 in Bel Air, CA.

Share With

Tuesday, August 08, 2017

   

© 2017 Stock News Now